Cargando…

Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report

Project Santa Fe was established both to provide thought leadership and to help develop the evidence base for the valuation of clinical laboratory services in the next era of American healthcare. The participants in Project Santa Fe represent major regional health systems that can operationalize lab...

Descripción completa

Detalles Bibliográficos
Autores principales: Crawford, James M., Shotorbani, Khosrow, Sharma, Gaurav, Crossey, Michael, Kothari, Tarush, Lorey, Thomas S., Prichard, Jeffrey W., Wilkerson, Myra, Fisher, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497901/
https://www.ncbi.nlm.nih.gov/pubmed/28725789
http://dx.doi.org/10.1177/2374289517701067
_version_ 1783248212274970624
author Crawford, James M.
Shotorbani, Khosrow
Sharma, Gaurav
Crossey, Michael
Kothari, Tarush
Lorey, Thomas S.
Prichard, Jeffrey W.
Wilkerson, Myra
Fisher, Nancy
author_facet Crawford, James M.
Shotorbani, Khosrow
Sharma, Gaurav
Crossey, Michael
Kothari, Tarush
Lorey, Thomas S.
Prichard, Jeffrey W.
Wilkerson, Myra
Fisher, Nancy
author_sort Crawford, James M.
collection PubMed
description Project Santa Fe was established both to provide thought leadership and to help develop the evidence base for the valuation of clinical laboratory services in the next era of American healthcare. The participants in Project Santa Fe represent major regional health systems that can operationalize laboratory-driven innovations and test their valuation in diverse regional marketplaces in the United States. We provide recommendations from the inaugural March 2016 meeting of Project Santa Fe. Specifically, in the transition from volume-based to value-based health care, clinical laboratories are called upon to provide programmatic leadership in reducing total cost of care through optimization of time-to-diagnosis and time-to-effective therapeutics, optimization of care coordination, and programmatic support of wellness care, screening, and monitoring. This call to action is more than working with industry stakeholders on the basis of our expertise; it is providing leadership in creating the programs that accomplish these objectives. In so doing, clinical laboratories can be effectors in identifying patients at risk for escalation in care, closing gaps in care, and optimizing outcomes of health care innovation. We also hope that, through such activities, the evidence base will be created for the new value propositions of integrated laboratory networks. In the very simplest sense, this effort to create “Clinical Lab 2.0” will establish the impact of laboratory diagnostics on the full 100% spend in American healthcare, not just the 2.5% spend attributed to in vitro diagnostics. In so doing, our aim is to empower regional and local laboratories to thrive under new models of payment in the next era of American health care delivery.
format Online
Article
Text
id pubmed-5497901
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-54979012017-07-06 Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report Crawford, James M. Shotorbani, Khosrow Sharma, Gaurav Crossey, Michael Kothari, Tarush Lorey, Thomas S. Prichard, Jeffrey W. Wilkerson, Myra Fisher, Nancy Acad Pathol Regular Article Project Santa Fe was established both to provide thought leadership and to help develop the evidence base for the valuation of clinical laboratory services in the next era of American healthcare. The participants in Project Santa Fe represent major regional health systems that can operationalize laboratory-driven innovations and test their valuation in diverse regional marketplaces in the United States. We provide recommendations from the inaugural March 2016 meeting of Project Santa Fe. Specifically, in the transition from volume-based to value-based health care, clinical laboratories are called upon to provide programmatic leadership in reducing total cost of care through optimization of time-to-diagnosis and time-to-effective therapeutics, optimization of care coordination, and programmatic support of wellness care, screening, and monitoring. This call to action is more than working with industry stakeholders on the basis of our expertise; it is providing leadership in creating the programs that accomplish these objectives. In so doing, clinical laboratories can be effectors in identifying patients at risk for escalation in care, closing gaps in care, and optimizing outcomes of health care innovation. We also hope that, through such activities, the evidence base will be created for the new value propositions of integrated laboratory networks. In the very simplest sense, this effort to create “Clinical Lab 2.0” will establish the impact of laboratory diagnostics on the full 100% spend in American healthcare, not just the 2.5% spend attributed to in vitro diagnostics. In so doing, our aim is to empower regional and local laboratories to thrive under new models of payment in the next era of American health care delivery. SAGE Publications 2017-04-18 /pmc/articles/PMC5497901/ /pubmed/28725789 http://dx.doi.org/10.1177/2374289517701067 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Regular Article
Crawford, James M.
Shotorbani, Khosrow
Sharma, Gaurav
Crossey, Michael
Kothari, Tarush
Lorey, Thomas S.
Prichard, Jeffrey W.
Wilkerson, Myra
Fisher, Nancy
Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report
title Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report
title_full Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report
title_fullStr Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report
title_full_unstemmed Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report
title_short Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report
title_sort improving american healthcare through “clinical lab 2.0”: a project santa fe report
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497901/
https://www.ncbi.nlm.nih.gov/pubmed/28725789
http://dx.doi.org/10.1177/2374289517701067
work_keys_str_mv AT crawfordjamesm improvingamericanhealthcarethroughclinicallab20aprojectsantafereport
AT shotorbanikhosrow improvingamericanhealthcarethroughclinicallab20aprojectsantafereport
AT sharmagaurav improvingamericanhealthcarethroughclinicallab20aprojectsantafereport
AT crosseymichael improvingamericanhealthcarethroughclinicallab20aprojectsantafereport
AT kotharitarush improvingamericanhealthcarethroughclinicallab20aprojectsantafereport
AT loreythomass improvingamericanhealthcarethroughclinicallab20aprojectsantafereport
AT prichardjeffreyw improvingamericanhealthcarethroughclinicallab20aprojectsantafereport
AT wilkersonmyra improvingamericanhealthcarethroughclinicallab20aprojectsantafereport
AT fishernancy improvingamericanhealthcarethroughclinicallab20aprojectsantafereport